Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Hirawat Samit (CIK 1781290) reported 2 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy PCRX (6,405 shares), Buy BMY (4,250 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Pacira BioSciences, Inc. (PCRX) | Director | Buy | 6,405 | $0 |
| 2025-04-29 | BRISTOL MYERS SQUIBB CO (BMY) | EVP,Chief Med.Offr.,Drug Dev. | Buy | 4,250 | $202,215 |
Source: SEC Form 4 filings · as of 2026-06-12